PFIZER - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.2

💊 Intraday Trading Analysis for PFIZER India

📊 Technical & Momentum Overview

Current Price: ₹5,192 — trading below 50 DMA (₹5,255) but above 200 DMA (₹5,059), suggesting short-term weakness within a longer-term uptrend.

RSI at 47.3: Neutral zone, indicating indecision and lack of strong momentum.

MACD at -39.2: Bearish crossover, signaling downward pressure.

Volume: 19.9K vs 17.7K average — slightly above average, but still low for aggressive intraday moves.

📈 Fundamental Snapshot

Strong ROCE (21.6%) & ROE (16.4%): Solid operational efficiency.

Low Debt-to-Equity (0.01): Excellent financial health.

Quarterly PAT: ₹192 Cr vs ₹198 Cr — stable earnings.

High PEG Ratio (22.2): Indicates overvaluation relative to growth.

Institutional Activity: Marginal increase in FII/DII holdings — mildly positive sentiment.

🎯 Intraday Strategy

✅ Optimal Buy Price

Buy Zone: ₹5,170–₹5,190

Entry near minor support; confirm with MACD flattening and RSI holding above 45.

💰 Profit-Taking Levels

Target 1: ₹5,225 (minor resistance)

Target 2: ₹5,255 (50 DMA resistance)

Aggressive Target: ₹5,280+ only if RSI crosses 50 and MACD turns positive

🛡️ Stop-Loss

Stop-Loss Level: ₹5,140

Breach below this level signals breakdown risk and invalidates intraday setup.

🕒 Exit Strategy If Already Holding Today

Exit on Strength

If price nears ₹5,255–₹5,280 and RSI rises above 50 with volume surge, consider booking profits.

Exit on Weakness

If MACD continues to decline and price fails to hold ₹5,170, exit to avoid deeper downside.

Volume drop below 18K with price rejection at ₹5,225 is a strong exit signal.

PFIZER shows a cautious intraday setup today — technically weak but fundamentally stable. Best suited for scalping trades with tight risk control. Let me know if you'd like to track this live or compare with other pharma stocks.

Edit in a page